問卷
此案目前為暫存狀態
編修至YYYY/MM/DD
不開放編輯功能
Find Division/Department
National Taiwan University Hospital
All Location
All Division/Department
篩選
Developmental Phase
Phase I
Phase I/II
Phase II
Phase II/III
Phase III
Phase IV
Others
Trial Status
Not yet recruiting
Active
Completed
Recruitment Status
Recruiting
Terminated
Stop recruiting
Suspended
Study ended
Trial scale
Multi-Regional Multi-Center
Taiwan Multiple Center
Taiwan Single Center
The expected start time interval of the test
Trial Applicant
Hospital/Foundation
Pharmaceutical/Biopharmaceutical company
Contract Research Organization
Important Roles
Asia Regional PI
Taiwan National PI
Chairman/Global PI
Steering Committee
Advisory board
None
Audit by Sponsors/CRO
Sponsors
CRO
Investigator-initiated trial(IIT)
Yes
Filters
下載
2020-04-13 - 2024-11-19
Condition/Disease
myelodysplastic syndrome (MDS)/CMML-2
Test Drug
MBG453
Participate Sites7Sites
Recruiting7Sites
2022-02-28 - 2025-08-18
Participate Sites1Sites
Recruiting1Sites
2023-09-15 - 2025-10-22
overweight and obesity
injection
Participate Sites5Sites
Recruiting5Sites
2021-04-01 - 2029-09-13
non-cirrhotic non-alcoholic steatohepatitis
Semaglutide D
Participate Sites10Sites
Not yet recruiting3Sites
2022-09-01 - 2025-03-07
Participate Sites4Sites
Recruiting4Sites
2016-10-13 - 2017-10-13
Participate Sites2Sites
Terminated2Sites
2021-05-18 - 2026-08-21
2023-12-15 - 2028-12-15
Participate Sites3Sites
Not yet recruiting2Sites
2022-11-01 - 2027-02-22
Not yet recruiting1Sites
2023-04-03 - 2025-09-01
全部
